US EditionRemedy Plan Therapeutics Raises $18M Financing
Summary by FinSMEs
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Remedy Plan Therapeutics Raises $18M Financing
Remedy Plan Therapeutics, a Gaithersburg, MD-based clinical-stage pharmaceutical company developing new, hyperbolic NAMPT inhibitors, raised $18M in funding. Backers included Schooner Capital, Alexandria Venture Investments, and other existing investors. The company intends to use the funds to accelerates advancement of RPT1G, a novel NAMPT inhibitor, into a Phase 1/2 trial in patients with acute myeloid […] The post Remedy Plan Therapeutics Rai…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
